It is possible, therefore, that the presently observed correlation between mortality and RDW of the CLL patients is affected by their metabolically driven (growth factor - IGF-1/mTOR)- rather than chronological- aging. This evidence concerns the gene MTOR and B-cell chronic lymphocytic leukemia.